Company: HURA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047921
Chunk: 284

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1B
Chunk 284
---
 based on the Articles. Holders of common stock are entitled to one vote for each share of common stock. As of December 31, 2024, there were 42,323,759 shares of common stock outstanding, of which 4,730 are unregistered shares of warrants exercised after the merger.Preferred Stock – The Company is authorized to issue up to 5,000,000 shares of Preferred Stock based on the Articles. The historical Kineta Series A Preferred Stock were assumed from the merger and outstanding and have a stated value of $278,530 as of December 31, 2024.Warrants – The following table summarizes the Company’s outstanding common stock warrants as of December 31, 2024 

        Outstanding

        Weighted averageexercise price

        Expiration dates

        Historical TuHURA common stock warrants

        10,592,387

        $
        4.16

        February 2025 to August 2029

        Historical Kintara common stock warrants

        17,468

        $
        1,362.41

        March 2025 to April 2027

        2024 common stock warrants issued to financial advisor

        297,029

        $
        0.01

        April 2027
       
       Warrant modificationIn August 2024, the Company extended the exercise period of its common stock purchase warrants issued in connection with Legacy TuHURA Series A Preferred Stock (the “Series A Warrants”) for an additional six months, with a new expiry date of February 12, 2025. There were no other changes in the terms of the Series A Warrants. As a result, a deemed dividend to the holders of the Series A Warrants in the amount of $965,177 was recorded as an increase in the net loss attributable to the common stockholders for 

F-22

TUHURA BIOSCIENSES, INC AND SUBSIDIARIESNotes to the consolidated financial statementsFor the years ended December 31, 2024, and 2023  

the year ended December 31, 2024. The incremental value associated with the warrant modification was determined using a Black-Sholes pricing model using the original terms of the warrants and the modified terms of the warrants and the following assumptions: expected term of approximately 0.1 - 0.6 years, dividend yield of 0.0%, volatility of 75% -112%, and a